It is necessary to carefully assess the clinical condition of patients with CF: if patients with the same established CFTR genotypes have serious differences in the manifestation of the disease, then additional extended molecular studies should be carried out to exclude complex alleles in those patients. This evidence concerns the gene CFTR and cystic fibrosis.